2Haverkate F.Thompson SG,Pyke SDM.et al.Production of Creactive protein and risk of coronary events in stable and unstable angina.Lancet.1 997,349:462～466.
3Liuzzo G,Buffon A.Biasucci LM.et al.Enhanced inflammatory response to coronary angioplasty in patients with severe unstable angina.Circulation,1998,98:2370～2376.
4Plenge JK.Hernandez TL.Weil KM,et al. Simvastatin lowers Creactive protein within 14 days:an effect independent of Iowdensity lipoprotein cholesterol reduction.Circulation,2002,106:1447～1452.
同被引文献6
1Schieffer B, Bunte C, Witte J, et al. Comparative effects of AT1-antagonism and angiotensin-converting enzyme inhibition on markers of inflammation and platelet aggregation in patients with coronary artery disease[J]. J Am Coll Cardiol, 2004,44(2):362-368.
2Saito M, Ishimitsu T, Minami J, et al. Realations of highsensitivity C-reactive protein to traditional cardiovascular risk factors[J]. Atherosclerosis, 2003,167(1):73-79.
3Minako YT, Taiki T,Takashi M, et al. C-roaetive protein-induced production of interleukin -18 in human endothelial cells : a mechanism of orchestrating eytikine cascade in acute coronary syndrome [ J ]. Heart Vessels,2003,18(4) :183-187.
4Williams TN, Zhang CX, Game BA, et al. C-reactive protein stimulates MMP-1 expression in U937 histiocytes through FcγRII and extracellular signal-regulated kinase pathway: an implication of CRP involvement in plaque destabilization[ J]. Artefioseler Thromb Vase Biol,2004,24 (1) :61-66.
5Ishii J, Wang JH, Naruse H, et al. Serum concentration of myoglobin vs human heart-type cytoplasmic fatty acid-binding protein in early detection of acute myocardial infarction [ J ]. Clin Chem, 1997, 43(8) :1372-1378.
